Orphan Drug Designation applies to approximately 50,000 Patients who predominantly suffer from severe chronic pain due to ...
The X4 Air is smaller and lighter than the company's flagship X4 and X5 models, but still records 8K videos and takes ...
Tourmaline went public in 2023 via a reverse merger with the struggling cell therapy developer Talaris. The deal gave Tourmaline funds to develop pacibekitug, an antibody that targets interleukin-6, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback